SCHEMBL330154

SCHEMBL330154

CCOC(=O)C12CC1C=CCCCCCC(N)C(=O)N1CC(OC(=O)N3CCc4ccccc4C3)CC1C(=O)N2

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ HPGD P15428 2/20 0.31
▸ BCL2 P10415 1/20 0.31
▸ KEAP1 Q14145 1/20 0.31
▸ DPP8 Q6V1X1 1/20 0.31
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330152 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3971556 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3968261 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3968264 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3968258 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3971549 1.00 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL8278978 0.95 ADRB3 (0.36) ADRB3ADRA2BADRA2C
SCHEMBL13923947 0.91 ADRB3 (0.36) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3965128 0.90 ADRB3 (0.45) ADRB3ADRA2BADRA2CALDH1A1KDM4E
SCHEMBL3965120 0.90 ADRB3 (0.45) ADRB3ADRA2BADRA2CALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680137-B1 Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication HOFFMANN LA ROCHE (CH) 2012-11-21 — — EP disclosed
EP-2407470-A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication F. Hoffmann-La Roche Ltd. (CH) 2012-01-18 — — EP disclosed
US-7491794-B2 Macrocyclic compounds as inhibitors of viral replication INTERMUNE, INC. (US) 2009-02-17 — — US disclosed
Send feedback